Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

ADA 2026 5 - 8 June 2026

Cardiometabolic Outcomes in Adults With Type 2 Diabetes Treated With 1 mg Semaglutide Who Titrate to 2 mg Semaglutide vs Switch to Tirzepatide

Authors :

Gang Fang¹; Chalak Muhammad¹; Caroline Swift¹; Josh Noone¹; Yuanjie Liang¹; Kathryn Tierney²

Affiliations

View Details Hide Details

Download .PDF

Keywords

Diabetes

Congress poster

GLP-1 RA

Semaglutide

RWE HEOR